In ATTAIN-MAINTAIN, patients who had plateaued after injectable therapy switched to oral orforglipron, marketed as Foundayo
With the advancement of immunotherapeutic technologies, the targeting potential of TLRs in cancer and infectious disease treatment has become increasingly evident, and TLR ligands, as key functional molecules for these targets, demonstrate substantial therapeutic promise
This is a well-established mechanism in the scientific literature, with multiple independent studies confirming the butyrate-to-GLP-1 signaling pathway
Since 2003, we continuously strive to innovate, inspire, and improve solutions for physicians by providing an exceptional personalized experience with the most accurate testing
The medication works by mimicking the bodys natural GLP-1 hormone, which stimulates insulin production and promotes feelings of satiety